INREBIC
Impact Biomedicines, Inc.
The mark consists of a prism in the shape of a V made up varying colors of blue and grey over the letter "E" of "INREBIC" in blue block lettering.
Mark For: INREBIC® trademark registration is intended to cover the categories of
>The color(s) blue and grey is/are claimed as a feature of the mark. The mark consists of a prism in the shape of a V made up varying colors of blue and grey over the letter "E" of "INREBIC" in blue block lettering.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88207119 |
| Registration Number | 5962898 |
| Mark Literal Elements | INREBIC |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-12-06 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Camille M. Miller |
| Attorney Docket Number | CELG1911US/4 |
Timeline
| 2018-11-27 | Application Filed |
| 2018-12-14 | Location: NEW APPLICATION PROCESSING |
| 2018-12-14 | Status: Live/Pending |
| 2019-01-04 | Transaction Date |
| 2019-04-09 | Published |
| 2019-04-09 | Published for Opposition |
| 2019-08-16 | Date of First Use |
| 2019-08-16 | Date of Use In Commerce |
| 2019-12-06 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-01-14 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-01-14 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  IMPACT BIOMEDICINES, INC. |
| Address | 86 MORRIS AVENUE SUMMIT, NEW JERSEY UNITED STATES 07901 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
| Party: | Celgene Corporation |
| Address | 86 Morris Avenue Summit DE 07901 |
| Legal Entity Type | |
| Legal Entity State | DE |
*multiple parties listed, check assignment documents for ownership information
Documents
 Drawing | JPEG | 2018-11-27 |
 TEAS RF New Application | MULTI | 2018-11-27 |
| Design Search Code Corr Project | APPLICATION/XML | 2018-12-15 |
| Preliminary Amendment | MULTI | 2019-01-04 |
| Amendment and Mail Process Complete | MULTI | 2019-01-11 |
| XSearch Search Summary | XML | 2019-02-25 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-02-27 |
| Notice of Publication | XML | 2019-03-20 |
| Notification Of Notice of Publication | XML | 2019-03-20 |
| OG Publication Confirmation | XML | 2019-04-09 |
| Notice of Allowance | APPLICATION/XML | 2019-06-04 |
| Specimen | JPEG | 2019-10-07 |
| Statement of Use | MULTI | 2019-10-07 |
| ITU Unit Action | MULTI | 2019-10-26 |
| Offc Action Outgoing | XML | 2019-11-15 |
| Response to Office Action | MULTI | 2019-11-22 |
| Specimen | JPEG | 2019-11-22 |
| Amendment and Mail Process Complete | MULTI | 2019-12-06 |
| Notice of Acceptance of Statement of Use | XML | 2019-12-07 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-12-07 |
| Registration Certificate | 2020-01-14 |
Design Search Codes
| 261905 | Prisms; Pyramids |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system. FIRST USE: 20190816. FIRST USE IN COMMERCE: 20190816
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system |
| CC0000 | The color(s) blue and grey is/are claimed as a feature of the mark. |
Related Filings
| Mark | Serial Number | Relationship Number |
|---|---|---|
| INREBIC | 86690908 | 4931750 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-01-14 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-12-07 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-12-06 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-05 | 68171 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-05 | 68171 |
| ASSIGNED TO LIE | 2019-12-02 | 68171 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-22 | |
| SU - NON-FINAL ACTION - WRITTEN | 2019-11-15 | 93926 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-15 | |
| NON-FINAL ACTION E-MAILED | 2019-11-15 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-10-25 | 65362 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-10-25 | 65362 |
| USE AMENDMENT FILED | 2019-10-07 | 65362 |
| TEAS STATEMENT OF USE RECEIVED | 2019-10-07 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-06-04 | |
| PUBLISHED FOR OPPOSITION | 2019-04-09 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-04-09 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-03-20 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-02-26 | |
| ASSIGNED TO EXAMINER | 2019-02-25 | 93926 |
| PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2019-01-10 | 70997 |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-01-09 | |
| ASSIGNED TO LIE | 2019-01-09 | 70997 |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2019-01-04 | |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-12-15 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-12-14 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-11-30 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 INREBIC 88207119 not registered Live/Pending |
Celgene Corporation 2018-11-27 |
 INREBIC 86690908 4931750 Live/Registered |
IMPACT BIOMEDICINES, INC. 2015-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 